1. Home
  2. SBXD vs CADL Comparison

SBXD vs CADL Comparison

Compare SBXD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBXD
  • CADL
  • Stock Information
  • Founded
  • SBXD 2024
  • CADL 1999
  • Country
  • SBXD United States
  • CADL United States
  • Employees
  • SBXD N/A
  • CADL N/A
  • Industry
  • SBXD
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBXD
  • CADL Health Care
  • Exchange
  • SBXD NYSE
  • CADL Nasdaq
  • Market Cap
  • SBXD 257.1M
  • CADL 306.4M
  • IPO Year
  • SBXD 2024
  • CADL 2021
  • Fundamental
  • Price
  • SBXD $10.20
  • CADL $5.57
  • Analyst Decision
  • SBXD
  • CADL Strong Buy
  • Analyst Count
  • SBXD 0
  • CADL 4
  • Target Price
  • SBXD N/A
  • CADL $21.00
  • AVG Volume (30 Days)
  • SBXD 5.5K
  • CADL 1.0M
  • Earning Date
  • SBXD 01-01-0001
  • CADL 03-13-2025
  • Dividend Yield
  • SBXD N/A
  • CADL N/A
  • EPS Growth
  • SBXD N/A
  • CADL N/A
  • EPS
  • SBXD N/A
  • CADL N/A
  • Revenue
  • SBXD N/A
  • CADL N/A
  • Revenue This Year
  • SBXD N/A
  • CADL N/A
  • Revenue Next Year
  • SBXD N/A
  • CADL N/A
  • P/E Ratio
  • SBXD $49.69
  • CADL N/A
  • Revenue Growth
  • SBXD N/A
  • CADL N/A
  • 52 Week Low
  • SBXD $9.95
  • CADL $1.56
  • 52 Week High
  • SBXD $10.40
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • SBXD N/A
  • CADL 30.13
  • Support Level
  • SBXD N/A
  • CADL $7.85
  • Resistance Level
  • SBXD N/A
  • CADL $8.69
  • Average True Range (ATR)
  • SBXD 0.00
  • CADL 0.62
  • MACD
  • SBXD 0.00
  • CADL -0.33
  • Stochastic Oscillator
  • SBXD 0.00
  • CADL 4.60

About SBXD SILVERBOX CORP IV

SilverBox Corp IV is a blank check company.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: